{"name":"BioLeaders Corporation","slug":"bioleaders-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BLS-ILB-E710c","genericName":"BLS-ILB-E710c","slug":"bls-ilb-e710c","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BLS-ILB-E710c","genericName":"BLS-ILB-E710c","slug":"bls-ilb-e710c","phase":"phase_2","mechanism":"BLS-ILB-E710c is an investigational drug with unknown mechanism of action.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPanFySlVLZ2hLUGhmcDNFXzBEMXBtMU82UXBqYncyUDc4ZVV1TGE4WUpjODE5TDZxV043eWZtYkI3T0Zmcm9NRGtWQkh6bkgzNVktUVU0aU5DenZBMjRKdVJfLWNydHgycE9qdEhOMVM2RzVTd2o1YVM3d1hxSUtNbEo3dDdGbEpIckFsMjR6cEJSb1B0UmlnTkFFSzdHdnV5azk2VjdCaFVXV1BHeTQxR1hEeWxYUW9pUTNWZXh4WDllbTB4UTRYOGlqUW5yUmNIVmxjemdCNG1pMG9BMTNWSw?oc=5","date":"2025-10-29","type":"pipeline","source":"EQS News","summary":"\"Korea Night\" to Bring Global Bio Leaders Together at BIO Europe 2025 | Corporate - EQS News","headline":"\"Korea Night\" to Bring Global Bio Leaders Together at BIO Europe 2025 | Corporate","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}